Empirical Financial Services, LLC d.b.a. Empirical Wealth Management
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1510434
Seattle, WA
Position in ACRS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$85,020
New position
Shares Held
16,072
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 5 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 94.09532105525138.ToString("F0")%
Shared 0.ToString("F0")%
None 5.904678944748632.ToString("F0")%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $12,687,043 across 17 Biotechnology names. ACRS ranks #16 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
73,041 | $2,295,678 | |
| 2 | INBX |
Inhibrx Biosciences, Inc.
|
22,584 | $2,139,834 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
19,312 | $1,837,923 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
7,464 | $1,798,599 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
15,916 | $1,298,267 | |
| 6 | EXEL |
Exelixis, Inc.
|
10,083 | $548,615 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
11,831 | $430,766 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
15,489 | $391,871 |
All Filings in ACRS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,020 | 16,072 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||